Exosome-based nanoimmunotherapy targeting TAMs, a promising strategy for glioma

Nature·Apr 3

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Research is exploring various strategies for glioma therapy, including exosome-based nanoimmunotherapy and other novel drug delivery systems. These approaches aim to enhance precision in cancer treatment, with some studies focusing on targeted therapy and immune modulation. The effectiveness of these methods, which also include gene therapy and the use of engineered cells, is being investigated in various studies.

Full coverage

Advances and challenges in novel drug delivery systems for glioma therapy

Frontiers·Aug 20

Engineering HLA-G-targeted extracellular vesicles nanoplatform for enhanced cancer therapy through precise cancer drug delivery

Nature·Dec 13

Plant-derived extracellular nanovesicles: a promising biomedical approach for effective targeting of triple negative breast cancer cells

Frontiers·Jun 16

Enhancing precision in cancer treatment: the role of gene therapy and immune modulation in oncology

Frontiers·Dec 9

Amantadine against glioma via ROS-mediated apoptosis and autophagy arrest

Nature·Nov 15

The role of Vps4 in cancer development

Frontiers·Jul 1

Development and evaluation of curcumin nano-niosomes for glioma-targeted therapy

Nature·Mar 27

MR imaging tracking of inflammation-activatable engineered neutrophils for targeted therapy of surgically treated glioma

Nature·Nov 14

View original report at Nature ↗

Fetching the latest headlines…